• British Pharmacopoeia Volume I & II
  • Monographs: Medicinal and Pharmaceutical Substances

Cocaine

scroll to previous hit
scroll to next hit
General Notices

bp2013_v1_07_medicinal_and_pharmaceutical_substances_04 cocaine_1_bp2007_cs.png


C17H21NO4    303.4    50-36-2

Action and use

Local anaesthetic.

Definition

Cocaine is methyl (1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate and may be obtained from the leaves of Erythroxylum coca Lam. and other species of Erythroxylum or by synthesis. It contains not less than 98.0% and not more than 101.0% of C17H21NO4, calculated with reference to the dried substance.

Characteristics

Colourless crystals or a white, crystalline powder. Slightly volatile.

Practically insoluble in water; freely soluble in ethanol (96%) and in ether; soluble in arachis oil; slightly soluble in liquid paraffin.

Identification

The infrared absorption spectrum, Appendix II A, is concordant with the reference spectrum of cocaine (RS 071).

Tests
Melting point

96° to 98°, Appendix V A.

Specific optical rotation

In a 2.4 % w/v solution in 0.1m hydrochloric acid, -79 to -81, calculated with reference to the dried substance, Appendix V F.

Related substances

Carry out the method for liquid chromatography, Appendix III D, using the following solutions.

(1) 0.05% w/v of the substance being examined in the mobile phase

(2) Dilute 1 volume of solution (1) to 50 volumes with the mobile phase, dilute 5.0 mL of this solution to 100.0 mL with the mobile phase.

(3) Dissolve 25 mg of the substance being examined in 0.01m sodium hydroxide and dilute to 100.0 mL with the same solvent. Allow the solution to stand for 15 minutes.

chromatographic conditions

(a) Use a stainless steel column (15 cm × 4.6 mm) packed with base-deactivated octadecylsilyl silica gel for chromatography (5 µm) (Waters Symmetry is suitable).

(b) Use isocratic elution and the mobile phase described below.

(c) Use a flow rate of 1 mL per minute.

(d) Use a column temperature of 35°.

(e) Use a detection wavelength of 216 nm.

(f) Inject 20 µL of each solution.

mobile phase

1 volume of triethylamine, 200 volumes of tetrahydrofuran, 860 volumes of acetonitrile and 959 volumes of water.

system suitability

The test is not valid unless, in the chromatogram obtained with solution (3), the resolution factor between the peaks due to cocaine (retention time, about 7 minutes) and the degradation product is at least 5.0.

limits

In the chromatogram obtained with solution (1):

the area of any peak eluting after the principal peak is not greater than the area of the peak in the chromatogram obtained with solution (2) (0.1%);

the sum of the areas of any secondary peaks is not greater than 5 times the area of the principal peak in the chromatogram obtained with solution (2) (0.5%).

Disregard any peak with an area less than 0. 5 times the area of the principal peak in the chromatogram obtained with solution (2) (0.05 %).

Loss on drying

When dried to constant weight at 80°, loses not more than 0.5% of its weight, Appendix IX D. Use 1 g.

Sulfated ash

Not more than 0.1%, Appendix IX A.

Assay

Carry out Method I for non-aqueous titration, Appendix VIII A, using 0.7 g dissolved in 50 mL of 1,4-dioxan and crystal violet solution as indicator. Each mL of 0.1m perchloric acid VS is equivalent to 30.34 mg of C17H21NO4.

STORAGE

Cocaine should be stored protected from light.

IMPURITIES

bp2013_v1_07_medicinal_and_pharmaceutical_substances_04 cocaine_2_bp2007_cs.png


A. methyl (1R,2R,3S,5S)-8-methyl-3-[[(E)-3-phenylpropenoyl]oxy]-8-azabicyclo[3.2.1]octane-2-carboxylate (cinnamoylcocaine),

bp2013_v1_07_medicinal_and_pharmaceutical_substances_04 cocaine_3_bp2007_cs.png


B. bis[(1R,2R,3S,5S)-2-(methoxycarbonyl)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] (1r,2c,3t,4t)-2,4-diphenylcyclobutane-1,3-dicarboxylate (α-truxilline),

bp2013_v1_07_medicinal_and_pharmaceutical_substances_04 cocaine_4_bp2007_cs.png


C. bis[(1R,2R,3S,5S)-2-(methoxycarbonyl)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] (1r,2c,3t,4t)-3,4-diphenylcyclobutane-1,2-dicarboxylate (β-truxilline).